FDA Permanently Debars Two Clinical Trial Site Staff Members

J.W. Schomisch
March 14, 2022 at 03:57 PM EST
Two staff members at a Florida clinical trial site have been permanently debarred by the FDA from providing services to anyone who has an approved or pending drug product application. The debarments were based on the staff members’ felony convictions last year. Both worked at Tellus Clinical Research in Miami. According to the FDA's notice of the debarment, Eduardo Navarro wa... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Related Articles